Intraoral Device vs Facial Mask for Class III Treatment
Not Applicable
- Conditions
- Dentofacial Anomalies, Including MalocclusionClass III Malocclusion
- Registration Number
- NCT04387175
- Lead Sponsor
- Azienda Ospedaliero-Universitaria Careggi
- Brief Summary
The aim of this randomized controlled trail is to compare the efficacy of an intraoral device (the Carriere® Motion 3D™ Class III Appliance) with the facial mask for the early treatemnt of Class III malocclusion. This is a monocentric, parallel, controlled trial with blinded examiner.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
- age between 5 and 8 years
- prepubertal patients (cervical vertebral stage 1 or 2)
- Deciduous, early mixed, and intermediate mixed dentition (the lower deciduous canine should show at least 2/3 of the roots unresorbed)
- Presence of Class III skeletal imbalance (Wits appraisal equal to or smaller than
- 1 mm)
Exclusion Criteria
- Early root resorption of the lower deciduous canines
- Periodontal disease
- Neurologic diseases
- Nickel allergy
- Patients with cleft lip and palate or craniofacial syndromes
- Patients irradiated in the head and neck area
- Patients who have undergone chemiotherapy or immunosuppresive therapy in the previous 5 years
- Patients unable to be followed for at least 1 year
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Wits appraisal Change in Wits appraisal evaluated on the lateral cephalograms taken at the start and at the end of active treatment (6-10 months) Distance between the perpendiculars from points A and B on the maxilla and mandible, respectively, onto the occlusal plane
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Class III malocclusion correction with Carriere Motion 3D appliance?
How does intraoral device efficacy compare to facial mask in early Class III malocclusion treatment outcomes?
Are there specific biomarkers that predict response to orthodontic appliances in dentofacial anomalies?
What adverse events are associated with Carriere Motion 3D versus facial mask in pediatric Class III treatment?
What combination therapies enhance Class III malocclusion correction with orthodontic devices?